Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Advies: vergoed avalglucosidase alfa (Nexviadyme) voor behandeling ziekte van Pompe
jun 2024 | Neuro-musculair